Critical Care Diagnostics Market by Product and Geography - Forecast and Analysis 2021-2025

Published: Jul 2021 Pages: 120 SKU: IRTNTR43701

The critical care diagnostics market share is expected to increase by USD 1.83 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 17.4%.

This critical care diagnostics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers critical care diagnostics market segmentations by application (microbial and infectious disease testing, hematology testing, cardiac and lipid testing, coagulation testing, and others) and geography (North America, Europe, Asia, and ROW). The critical care diagnostics market report also offers information on several market vendors, including Abbott Laboratories, Becton, Dickinson and Co., bioMerieux SA, Bio Rad Laboratories Inc., Chembio Diagnostics Inc., Danaher Corp., EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Quidel Corp., and Siemens AG among others.

What will the Critical Care Diagnostics Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Critical Care Diagnostics Market Size for the Forecast Period and Other Important Statistics

 

Critical Care Diagnostics Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a positive impact on the market growth during and post COVID-19 era. The growing focus on diagnosis of chronic conditions and infectious diseases is notably driving the critical care diagnostics market growth, although factors such as lack of skilled professionals may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the critical care diagnostics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Critical Care Diagnostics Market Driver

One of the key factors driving the critical care diagnostics market growth is the growing focus on diagnosis of chronic conditions and infectious diseases. Chronic diseases and conditions such as diabetes, stroke, and cancers are diagnosed by using critical care diagnostics. According to the CDC report 2020, more than 34 million adults in the US or 11% of the total US population, have diabetes. The rate of diabetes that is diagnosed has increased with age. Among the adults aged 18-44 years, 4% had diabetes; among those aged 45-64 years, 17% had diabetes; while among those aged 65 years and older, 25% had diabetes. Serious conditions with a high mortality rate also incur greater patient costs and strengthen the impetus for rapid POC diagnosis. Thus, the regulatory authorities are approving the products for emergency use to identify and diagnose critical conditions. Thus, with the number of increasing cases of chronic disorders, the demand for POC products that are required during critical care diagnosis and treatment will increase, thereby contributing to the market growth globally.

Key Critical Care Diagnostics Market Trend

Data management and connectivity to EHRs through interoperability is the major trend influencing critical care diagnostics market growth. One of the major concerns with critical care diagnostics was that, while using the POC products in a critical care setting, the results were not captured electronically. Therefore, they are less accessible and are not included in data analytics. The results should be properly recorded and electronically linked with the EHR. Sometimes, the data will be available at the place of testing. However, once the patient leaves the testing location, results become unavailable unless the devices are connected to the laboratory information system (LIS) and/or EHR. Therefore, companies are focusing on providing the advanced technology of data management of the patients by introducing the advent of health information technology within the healthcare system. Manufacturers are also developing software for critical care diagnostics, where the data of each patient gets stored in the data warehouse through connectivity to EHRs by the interoperability method. The compliance of rapid diagnostic analyzers with LIS or EHRs is one of the emerging trends in a critical care setting, as most companies are shifting toward innovating their technology and products.

Key Critical Care Diagnostics Market Challenge

Lack of skilled professionals is one of the key challenges hindering the critical care diagnostics market growth. Most of the critical care diagnostic tests are performed in hospitals and physicians' offices by highly skilled staff. The popularity of critical care diagnostic testing is growing in developing countries. Most medical professionals lack knowledge about the technology, its benefits, and the handling of patients during POC testing. Also, many medical personnel is unfamiliar with routine laboratory procedures such as proper patient preparation, sample collection, calibration, instrument maintenance, and quality control. In the countries of Africa and in developing countries such as China, India, and Brazil, the lack of technical expertise in POC diagnosis delays the availability of test results, which, in turn, interrupts the treatment outcome. Many medical professionals are unable to interpret the basic test results during the test or identify the abnormalities under the microscope. This lack of expertise enhances the probability of a wrong diagnosis. Hence, it is important to educate medical professionals about the use of critical care diagnostic devices.

This critical care diagnostics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Parent Market Analysis

Technavio categorizes the global critical care diagnostics market as a part of the global healthcare supplies market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the critical care diagnostics market during the forecast period.

Who are the Major Critical Care Diagnostics Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • Abbott Laboratories
  • Becton, Dickinson and Co.
  • bioMerieux SA
  • Bio Rad Laboratories Inc.
  • Chembio Diagnostics Inc.
  • Danaher Corp.
  • EKF Diagnostics Holdings Plc
  • F. Hoffmann La Roche Ltd.
  • Quidel Corp.
  • Siemens AG

 

This statistical study of the critical care diagnostics market encompasses successful business strategies deployed by the key vendors. The critical care diagnostics market is fragmented and the vendors are deploying growth strategies such as organic and inorganic strategies to compete in the market.

Product Insights and News

  • Abbott Laboratories - The company offers solutions for critical care diagnostics under the brand name of Alinity. Alinity maximizes testing throughput with high quality assays to deliver efficient and accurate results for greater productivity. The 3 products that the company offers under the brand are Alinity c, Alinity i and Alinity ci.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The critical care diagnostics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Critical Care Diagnostics Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the critical care diagnostics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The report has further elucidated on other innovative approaches being followed by vendors to ensure a sustainable market presence.

Which are the Key Regions for Critical Care Diagnostics Market?

For more insights on the market share of various regions Request for a FREE sample now!

43% of the market's growth will originate from North America during the forecast period. US is the key market for critical care diagnostics in North America. Market growth in this region will be faster than the growth of the market in other regions.

In 2019, the number of weekly visits to the emergency department (ED) of hospitals was 2.1 million in the US. The average increase in emergency department visits increased by 25% in the past ten years. Therefore, the increasing number of hospital visits that require critical care diagnosis creates a demand in the market. This will facilitate the critical care diagnostics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

However, in early 2020, the outbreak of the COVID-19 pandemic led to a halt in the general operations of healthcare facilities and treatment centers in the region as they became more focused on treating COVID-19 patients, which restricted the number of critical care diagnoses and emergency department visits, which, in turn, negatively impacted the growth of the critical care diagnostics market in the region. For instance, according to CDC, ED visits in the US declined 42% during the early part of the COVID-19 pandemic, from 2.1 million per week to 1.2 million. Restrictions on medical tourism, following the imposition of restrictions on travel, also had a negative impact on the critical care diagnostics market, but the market is expected to grow after the pandemic is contained in the region.

What are the Revenue-generating Application Segments in the Critical Care Diagnostics Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The critical care diagnostics market share growth by the microbial and infectious disease testing will be significant during the forecast period. The prevalence of infectious diseases such as bacterial infections, respiratory diseases, and human papillomavirus (HPV) is gradually increasing globally.

Besides the above-mentioned factors, the post COVID-19 impact has brought forth a slowdown in or fast tracked the demand for the service or product. This report provides an accurate prediction of the contribution of all the segments to the growth of the critical care diagnostics market size and actionable market insights on post COVID-19 impact on each segment.

 

Critical Care Diagnostics Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 17.4%

Market growth 2021-2025

$ 1.83 billion

Market structure

Fragmented

YoY growth (%)

16.76

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 43%

Key consumer countries

US, UK, Japan, Germany, and France

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Abbott Laboratories, Becton, Dickinson and Co., bioMerieux SA, Bio Rad Laboratories Inc., Chembio Diagnostics Inc., Danaher Corp., EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Quidel Corp., and Siemens AG

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Critical Care Diagnostics Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive critical care diagnostics market growth during the next five years
  • Precise estimation of the critical care diagnostics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the critical care diagnostics industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of critical care diagnostics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 01: Parent market
    • Exhibit 02: Market characteristics
  • 2.2 Value chain analysis
    • Exhibit 03: Value Chain Analysis – Healthcare supplies

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 04: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 05: Market segments
  • 3.3 Market size 2020
    • 3.4 Market outlook: Forecast for 2020 - 2025
      • Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)
      • Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 08: Five forces analysis 2020 & 2025
    • 4.2 Bargaining power of buyers
      • Exhibit 09: Bargaining power of buyers
    • 4.3 Bargaining power of suppliers
      • Exhibit 10: Bargaining power of suppliers
    • 4.4 Threat of new entrants
      • Exhibit 11: Threat of new entrants
    • 4.5 Threat of substitutes
      • Exhibit 12: Threat of substitutes
    • 4.6 Threat of rivalry
      • Exhibit 13: Threat of rivalry
    • 4.7 Market condition
      • Exhibit 14: Market condition - Five forces 2020

    5 Market Segmentation by Application

    • 5.1 Market segments
      • Exhibit 15: Application - Market share 2020-2025 (%)
    • 5.2 Comparison by Application
      • Exhibit 16: Comparison by Application
    • 5.3 Microbial and infectious disease testing - Market size and forecast 2020-2025
      • Exhibit 17: Microbial and infectious disease testing - Market size and forecast 2020-2025 ($ million)
      • Exhibit 18: Microbial and infectious disease testing - Year-over-year growth 2020-2025 (%)
    • 5.4 Hematology testing - Market size and forecast 2020-2025
      • Exhibit 19: Hematology testing - Market size and forecast 2020-2025 ($ million)
      • Exhibit 20: Hematology testing - Year-over-year growth 2020-2025 (%)
    • 5.5 Cardiac and lipid testing - Market size and forecast 2020-2025
      • Exhibit 21: Cardiac and lipid testing - Market size and forecast 2020-2025 ($ million)
      • Exhibit 22: Cardiac and lipid testing - Year-over-year growth 2020-2025 (%)
    • 5.6 Coagulation testing - Market size and forecast 2020-2025
      • Exhibit 23: Coagulation testing - Market size and forecast 2020-2025 ($ million)
      • Exhibit 24: Coagulation testing - Year-over-year growth 2020-2025 (%)
    • 5.7 Others - Market size and forecast 2020-2025
      • Exhibit 25: Others - Market size and forecast 2020-2025 ($ million)
      • Exhibit 26: Others - Year-over-year growth 2020-2025 (%)
    • 5.8 Market opportunity by Application
      • Exhibit 27: Market opportunity by Application

    6 Customer Landscape

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 29: Market share by geography 2020-2025 (%)
    • 7.2 Geographic comparison
      • Exhibit 30: Geographic comparison
    • 7.3 North America - Market size and forecast 2020-2025
      • Exhibit 31: North America - Market size and forecast 2020-2025 ($ million)
      • Exhibit 32: North America - Year-over-year growth 2020-2025 (%)
    • 7.4 Europe - Market size and forecast 2020-2025
      • Exhibit 33: Europe - Market size and forecast 2020-2025 ($ million)
      • Exhibit 34: Europe - Year-over-year growth 2020-2025 (%)
    • 7.5 Asia - Market size and forecast 2020-2025
      • Exhibit 35: Asia - Market size and forecast 2020-2025 ($ million)
      • Exhibit 36: Asia - Year-over-year growth 2020-2025 (%)
    • 7.6 ROW - Market size and forecast 2020-2025
      • Exhibit 37: ROW - Market size and forecast 2020-2025 ($ million)
      • Exhibit 38: ROW - Year-over-year growth 2020-2025 (%)
    • 7.7 Key leading countries
      • Exhibit 39: Key leading countries
    • 7.8 Market opportunity by geography
      • Exhibit 40: Market opportunity by geography

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • Exhibit 41: Impact of drivers and challenges
      • 8.3 Market trends

        9 Vendor Landscape

        • 9.1 Vendor landscape
          • Exhibit 42: Vendor landscape
        • 9.2 Landscape disruption
          • Exhibit 43: Landscape disruption
          • Exhibit 44: Industry risks

        10 Vendor Analysis

        • 10.1 Vendors covered
          • Exhibit 45: Vendors covered
        • 10.2 Market positioning of vendors
          • Exhibit 46: Market positioning of vendors
        • 10.3 Abbott Laboratories
          • Exhibit 47: Abbott Laboratories - Overview
          • Exhibit 48: Abbott Laboratories- Business segments
          • Exhibit 49: Abbott Laboratories – Key news
          • Exhibit 50: Abbott Laboratories - Key offerings
          • Exhibit 51: Abbott Laboratories - Segment focus
        • 10.4 Becton, Dickinson and Co.
          • 10.5 bioMerieux SA
            • Exhibit 57: bioMerieux SA - Overview
            • Exhibit 58: bioMerieux SA - Business segments
            • Exhibit 59: bioMerieux SA – Key news
            • Exhibit 60: bioMerieux SA - Key offerings
            • Exhibit 61: bioMerieux SA - Segment focus
          • 10.6 Bio Rad Laboratories Inc.
            • Exhibit 62: Bio Rad Laboratories Inc. - Overview
            • Exhibit 63: Bio Rad Laboratories Inc. - Business segments
            • Exhibit 64: Bio Rad Laboratories Inc. - Key news
            • Exhibit 65: Bio Rad Laboratories Inc. - Key offerings
            • Exhibit 66: Bio Rad Laboratories Inc. - Segment focus
          • 10.7 Chembio Diagnostics Inc.
            • Exhibit 67: Chembio Diagnostics Inc. - Overview
            • Exhibit 68: Chembio Diagnostics Inc. - Business segments
            • Exhibit 69: Chembio Diagnostics Inc – Key news
            • Exhibit 70: Chembio Diagnostics Inc. - Key offerings
          • 10.8 Danaher Corp.
            • Exhibit 71: Danaher Corp. - Overview
            • Exhibit 72: Danaher Corp. - Business segments
            • Exhibit 73: Danaher Corp. – Key news
            • Exhibit 74: Danaher Corp. - Key offerings
            • Exhibit 75: Danaher Corp. - Segment focus
          • 10.9 EKF Diagnostics Holdings Plc
            • Exhibit 76: EKF Diagnostics Holdings Plc - Overview
            • Exhibit 77: EKF Diagnostics Holdings Plc - Business segments
            • Exhibit 78: EKF Diagnostics Holdings Plc – Key news
            • Exhibit 79: EKF Diagnostics Holdings Plc - Key offerings
            • Exhibit 80: EKF Diagnostics Holdings Plc - Segment focus
          • 10.10 F. Hoffmann La Roche Ltd.
            • Exhibit 81: F. Hoffmann La Roche Ltd. - Overview
            • Exhibit 82: F. Hoffmann La Roche Ltd. - Business segments
            • Exhibit 83: F. Hoffmann La Roche Ltd. - Key news
            • Exhibit 84: F. Hoffmann La Roche Ltd. - Key offerings
            • Exhibit 85: F. Hoffmann La Roche Ltd. - Segment focus
          • 10.11 Quidel Corp.
            • Exhibit 86: Quidel Corp. - Overview
            • Exhibit 87: Quidel Corp. - Business segments
            • Exhibit 88: Quidel Corp.– Key news
            • Exhibit 89: Quidel Corp. - Key offerings
            • Exhibit 90: Quidel Corp. - Segment focus
          • 10.12 Siemens AG
            • Exhibit 91: Siemens AG - Overview
            • Exhibit 92: Siemens AG - Business segments
            • Exhibit 93: Siemens AG – Key news
            • Exhibit 94: Siemens AG - Key offerings
            • Exhibit 95: Siemens AG - Segment focus

          11 Appendix

          • 11.1 Scope of the report
            • 11.2 Currency conversion rates for US$
              • Exhibit 96: Currency conversion rates for US$
            • 11.3 Research methodology
              • Exhibit 97: Research Methodology
              • Exhibit 98: Validation techniques employed for market sizing
              • Exhibit 99: Information sources
            • 11.4 List of abbreviations
              • Exhibit 100: List of abbreviations

            Research Framework

            Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

            INFORMATION SOURCES

            Primary sources

            • Manufacturers and suppliers
            • Channel partners
            • Industry experts
            • Strategic decision makers

            Secondary sources

            • Industry journals and periodicals
            • Government data
            • Financial reports of key industry players
            • Historical data
            • Press releases

            DATA ANALYSIS

            Data Synthesis

            • Collation of data
            • Estimation of key figures
            • Analysis of derived insights

            Data Validation

            • Triangulation with data models
            • Reference against proprietary databases
            • Corroboration with industry experts

            REPORT WRITING

            Qualitative

            • Market drivers
            • Market challenges
            • Market trends
            • Five forces analysis

            Quantitative

            • Market size and forecast
            • Market segmentation
            • Geographical insights
            • Competitive landscape

            PURCHASE FULL REPORT OF

            critical care diagnostics market market

            Key Questions Answered

            • What are the key global market and the regional market share?
            • What are the revenue-generating key market segments?
            • What are the key factors driving and challenging this market’s growth?
            • Who are the key market vendors and their growth strategies?
            • What are the latest trends influencing the growth of this market?
            • What are the variables influencing the market growth in the primary regions?
            • What are the factors influencing the growth of the parent market?

            Why should you prefer Technavio's market insights report?

            • Off-the-shelf research reports
            • Reports can be tailored to meet the customer's needs
            • Trusted by more than 100 fortune 500 organizations
            • Information about the market's key drivers, trends, and challenges
            • Parent market analysis
            • Every week, 50,000 people visit our subscription platform
            • Detailed vendors report with competitive landscape
            • Covid-19 impact and recovery analysis
            • Data on revenue-generating market segments
            • Details on the market shares of various regions
            • Five-force market analysis